Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

61.31 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 423
Open 61.31
Bid (Size) 60.75 (2)
Ask (Size) 60.94 (3)
Prev. Close 61.31
Today's Range 61.31 - 61.31
52wk Range 56.75 - 69.75
Shares Outstanding 2,222,113,553
Dividend Yield 3.20%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenoc
BMS Receives Positive CHMP Opinion for Opdivo + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal.... 
From Business Wire News Releases
Five-Year Data from CheckMate -214 Show Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Longest Median Overall Survival Currently Reported in Phase 3 Trial of Patients with Previously Untreat
Five-Year Data from CheckMate -214 Show Opdivo Plus Yervoy Demonstrates Longest Median Overall Survival Currently Reported in Phase 3 Trial..... 
From Business Wire News Releases

Performance

YTD
-0.11%
-0.11%
1 Month
-11.40%
-11.40%
3 Month
-8.26%
-8.26%
6 Month
-3.27%
-3.27%
1 Year
+6.13%
+6.13%

More News

Read More
Gritstone Unveils "Off-The-Shelf" Neoantigen Immunotherapy Data In Lung Cancer
Tags Phase 1 Trial Small Cap Biotech
From Benzinga
Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal Cancer
Tags News Briefs ESMO21
From Benzinga
These Industries Stand To Benefit From The Infrastructure Bill — And These Companies Are Lobbying Against It
Tags WBA American Families Plan Made in America Tax Plan
From Benzinga
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
Tags NVO PRTA RHHBY
From Motley Fool
Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy
Tags PFE Benzinga Market News
From Benzinga
Visualizing the World’s Biggest Pharmaceutical Companies
Tags Stocks / Equities Pharma/Biotech Healthcare
From TalkMarkets
Noteworthy Thursday Option Activity: ULTA, BMY, NKE
Tags Stocks
From Market News Video
According to New Multinational Survey, Healthcare Providers Believe Immunotherapy Has Potential to Positively Impact Earlier-Stage Cancer Treatment Landscape Across Tumor Types
From Business Wire News Releases
8 Health Care Stocks With Unusual Options Alerts In Today's Session
Tags SDC TRVN TDOC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.